FREE webinar
👩🏼💻 Secrets to Successful Glycemic Programs.
Register Now
877-349-4582
Request A Demo
Client Login
Search
Solutions
EndoTool Glucose Management System
EndoTool IV
EndoTool SubQ
Interoperability
Analytics
Professional Services
Why it Matters
Evidence
About
Company Overview
Leadership Team
Clinical Advisory Board
Newsroom
Partnerships
Careers
Resources
Blog
Contact
877-349-4582
Request A Demo
877-349-4582
Request A Demo
Blog
Computerized Dosing
,
EndoTool
,
Residual Insulin
/
Does Your Computerized Glycemic Management System Incorporate EREI?
Even though the protocol for dosing insulin can be carefully calculated for the particular patient in need, what if that patient’s need for insulin changes quickly after the initial dose recommendation? This concept is not only unheard of, it is very common. Based on a wide range of factors, such as a patient’s activity level, meals consumed, and stress, a...
Computerized Dosing
EndoTool
Residual Insulin
EndoTool
,
Renal Failure
,
Residual Insulin
/
Effectively Managing Blood Glucose in Patients With Renal Failure
Kidneys can be injured by a number of reasons. In the United States alone, more than 26 million people are estimated to have chronic kidney disease (CKD), although most don’t know it because early signs are often missed. “While diabetes is the leading cause of kidney failure that does not mean that everyone with diabetes will develop CKD severe enough...
EndoTool
Renal Failure
Residual Insulin
EndoTool
,
IV Insulin Dosing
,
Residual Insulin
/
Monarch Announces Groundbreaking EREI Technology
This past Wednesday, the team at Monarch Medical Technologies announced ground-breaking EREI technology for any hospital scenario where intravenous insulin is administered. Dr. Patrick Burgess, founder and inventor of EndoTool, described the technology as having the potential to nearly eliminate severe hypoglycemia while removing the risk of human oversight. EREI refers to “estimated residual extracellular insulin” present in a patient’s...
EndoTool
IV Insulin Dosing
Residual Insulin
EndoTool
,
Personalized Dosing
,
Residual Insulin
/
Estimated Residual Extracellular Insulin (EREI): What Is It?
Estimated residual extracellular insulin, or EREI, refers to residual insulin present in a patient’s body. Every patient receiving insulin therapy requires personalized treatment based on their individual makeup. In addition to this, each patient’s need for insulin is not only different, but, ever-changing based on activity level, meals consumed and stress. The amount of residual insulin present in a person’s...
EndoTool
Personalized Dosing
Residual Insulin
EndoTool
,
Residual Insulin
/
The Importance of Managing Residual Insulin
While dosing protocols may be carefully calculated, a hospitalized patient’s need for insulin may change quickly based on a wide range of factors. Insulin therapy must follow suit. Compared to paper protocols and lookup tables, computerized insulin management solutions enhance ease of use and accuracy. However, many computerized systems rely on the same imprecise protocols as manual methods and fall...
EndoTool
Residual Insulin
Search
Submit
Clear
Tags
A1C
ADA
CMS
Computerized Dosing
Conferences
Cost Savings
COVID-19
Diabetes
DKA
EMR Integration
EndoTool
Gestational Diabetes
Glycemic Management
Glycemic Steering Committee
Guidelines and Standards
Heart Failure
Hyperglycemia
Hypoglycemia
Hypothermia
Insulin
IV Insulin Dosing
Nursing
Obstetrics
Patient Safety
Performance Improvement
Personalized Dosing
Pharmacy
Renal Failure
Residual Insulin
Society of Hospital Medicine
SubQ Insulin Dosing
Surgical Site Infection
The Joint Commission
Transition IV to SubQ
Trauma
Workflow
Search
Submit
Clear
Client Login
Search
Submit
Clear
Solutions
EndoTool Glucose Management System
EndoTool IV
EndoTool SubQ
Interoperability
Analytics
Professional Services
Why it Matters
Evidence
About
Company Overview
Leadership Team
Clinical Advisory Board
Newsroom
Partnerships
Careers
Resources
Blog
Contact
Scroll Up